Amniotic-fluid Lactoferrin: A Marker for Subclinical Intraamniotic Infection Prior to 32 Weeks Gestation

Kimberly A. Heller; Phillip C. Greig; R. Phillip Heine

doi:10.1155/S1064744995000573

Infectious Diseases in Obstetrics and Gynecology (Jan 1995)

Amniotic-fluid Lactoferrin: A Marker for Subclinical Intraamniotic Infection Prior to 32 Weeks Gestation

Kimberly A. Heller,
Phillip C. Greig,
R. Phillip Heine

Affiliations

Kimberly A. Heller: Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh, Pittsburgh, PA, USA
Phillip C. Greig: Department of Obstetrics and Gynecology, Duke University, Durham, NC, USA
R. Phillip Heine: Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh, Pittsburgh, PA, USA

DOI: https://doi.org/10.1155/S1064744995000573
Journal volume & issue: Vol. 3, no. 5
pp. 179 – 183

Abstract

Read online

Objective: Lactoferrin is a glycoprotein released from the secondary granules of activated neutrophils in the setting of infection. The purpose of this study was to determine if amniotic-fluid (AF) lactoferrin levels are elevated in preterm labor (PTL) patients with subclinical intraamniotic infection (IAI).

Published in Infectious Diseases in Obstetrics and Gynecology

ISSN: 1064-7449 (Print); 1098-0997 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Gynecology and obstetrics; Medicine: Internal medicine: Infectious and parasitic diseases
Website: https://onlinelibrary.wiley.com/journal/7281

About the journal